Correlation Between Delaware Healthcare and Vanguard Developed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Delaware Healthcare and Vanguard Developed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Delaware Healthcare and Vanguard Developed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Delaware Healthcare Fund and Vanguard Developed Markets, you can compare the effects of market volatilities on Delaware Healthcare and Vanguard Developed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Delaware Healthcare with a short position of Vanguard Developed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Delaware Healthcare and Vanguard Developed.

Diversification Opportunities for Delaware Healthcare and Vanguard Developed

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Delaware and Vanguard is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Delaware Healthcare Fund and Vanguard Developed Markets in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard Developed and Delaware Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Delaware Healthcare Fund are associated (or correlated) with Vanguard Developed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard Developed has no effect on the direction of Delaware Healthcare i.e., Delaware Healthcare and Vanguard Developed go up and down completely randomly.

Pair Corralation between Delaware Healthcare and Vanguard Developed

Assuming the 90 days horizon Delaware Healthcare is expected to generate 2.73 times less return on investment than Vanguard Developed. But when comparing it to its historical volatility, Delaware Healthcare Fund is 1.08 times less risky than Vanguard Developed. It trades about 0.09 of its potential returns per unit of risk. Vanguard Developed Markets is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  2,509  in Vanguard Developed Markets on November 28, 2024 and sell it today you would earn a total of  85.00  from holding Vanguard Developed Markets or generate 3.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Delaware Healthcare Fund  vs.  Vanguard Developed Markets

 Performance 
       Timeline  
Delaware Healthcare 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Delaware Healthcare Fund has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Vanguard Developed 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Vanguard Developed Markets are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Vanguard Developed is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Delaware Healthcare and Vanguard Developed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Delaware Healthcare and Vanguard Developed

The main advantage of trading using opposite Delaware Healthcare and Vanguard Developed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Delaware Healthcare position performs unexpectedly, Vanguard Developed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard Developed will offset losses from the drop in Vanguard Developed's long position.
The idea behind Delaware Healthcare Fund and Vanguard Developed Markets pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements